All the news Showing 7 of 67 articles.Get an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Nucleoside analogues reduce hepatitis B liver cancer risk Liz Highleyman / 29 November 2012 Treatment of chronic hepatitis B with nucleoside analogues including lamivudine (Epivir) and entecavir (Baraclude) can reduce the risk of developing hepatocellular carcinoma, including cancer recurrence after successful resection surgery, according to data presented ... Tenofovir safe and effective for long-term hepatitis B treatment with little bone loss Liz Highleyman / 22 November 2012 Tenofovir (Viread) continues to be safe and effective for treating chronic hepatitis B through eight years of follow-up, researchers reported at The Liver Meeting 2012, the 63rd Annual Meeting of the American Association ... Switching to tenofovir suppresses hepatitis B in HIV/HBV co-infected people Liz Highleyman / 20 September 2012 People with HIV and hepatitis B virus (HBV) co-infection, who substituted tenofovir (Viread) for zidovudine (Retrovir) or abacavir (Ziagen) in their antiretroviral regimen, saw a reduction in hepatitis B viral load despite HBV ... Hepatitis B genotype B associated with poorer liver-related outcomes in Taiwanese patients co-infected with HIV and hepatitis B Michael Carter / 13 December 2011 Liver-related outcomes are poorer in HIV-positive patients who are co-infected with hepatitis B virus genotype B compared to co-infected patients with hepatitis B genotype C, Taiwanese investigators report in the online edition of ... New European HIV treatment guidelines expand treatment recommendations but anticipate possible drug shortages Gus Cairns / 18 October 2011 The new edition of the European AIDS Clinical Society (EACS) treatment guidelines for people with HIV was published last week at the 13th European AIDS Conference in Belgrade, Serbia. ... Lamivudine has limited impact on HBV for hepatitis B / HIV-coinfected in South African trial Keith Alcorn / 05 July 2011 The inclusion of lamivudine (3TC) in antiretroviral therapy had few additional benefits for South African HIV-positive patients co-infected with hepatitis B, South African investigators report in the online edition of AIDS. Hepatitis B virus (HBV) ... Entecavir and Truvada an option for HBV for treatment-experienced HIV/HBV-co-infected patients Michael Carter / 30 March 2011 A combination of entecavir with Truvada is an effective and safe option for HIV/hepatitis B-co-infected patients whose current therapy is not suppressing hepatitis B viral load, investigators from the north of England ... ← Prev1...34567Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive